Interaction databaseSupplement × PrescriptionReviewed May 2026

Lisinopril and Potassium, a caution.

ACE inhibitors like lisinopril reduce aldosterone secretion, which decreases renal potassium excretion and raises serum potassium. Additional potassium supplementation can cause dangerous hyperkalemia, leading to life-threatening cardiac arrhythmias. This is one of the most important drug-supplement interactions.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Lisinopril and Potassium
Pair type
Caution
Evidence (highest tier)
Strong
Source citations
4 sources
Stack Score effect
−5 to your Stack Score (per scored caution row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Caution · Strong evidence

Caution

What is happening. ACE inhibitors like lisinopril reduce aldosterone secretion, which decreases renal potassium excretion and raises serum potassium. Additional potassium supplementation can cause dangerous hyperkalemia, leading to life-threatening cardiac arrhythmias. This is one of the most important drug-supplement interactions.

Mechanism. Lisinopril inhibits ACE, reducing angiotensin II-stimulated aldosterone release. Without aldosterone, ENaC-mediated sodium reabsorption and ROMK-mediated potassium secretion in the collecting duct are both reduced. Exogenous potassium supplementation on top of this impaired excretion can rapidly cause hyperkalemia.

Recommendation. Do not take potassium supplements while on lisinopril unless specifically directed by your prescriber with regular potassium monitoring. Even potassium-rich salt substitutes should be avoided. Report symptoms of hyperkalemia (muscle weakness, irregular heartbeat, tingling).

Sources (4)
  1. Juurlink DN et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004;351(6):543-551. PMID 15295047
  2. Filippini T, Naska A, Kasdagli MI et al.. Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2020. PMID 32500831
  3. Behers BJ, Behers BM, Stephenson-Moe CA et al.. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length. Nutrients. 2024. PMID 39519450
  4. D'Elia L, Cappuccio FP, Masulli M et al.. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients. 2023. PMID 36839211

Stack Score

How this pair moves the number.

Effect on the composite score

If both Lisinopril and Potassium are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.